Fact CheckerSign in

NCT07019246Recruiting

Safety of Etomidate-propofol Mixture vs. Propofol for Total Intravenous Anesthesia in Elderly Patients Undergoing Abdominal Surgery

Safety of Etomidate-propofol Mixture vs. Propofol for Total Intravenous Anesthesia in Elderly Patients Undergoing Abdominal Surgery - A Randomized, Double-blind, Controlled Study

Source: ClinicalTrials.gov · Last updated 17 Jun 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The purpose of this study is to access the safety of etomidate - propofol mixture vs propofol for total intravenous anesthesia in elderly patients undergoing abdominal surgery.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
166 (estimated)
First submitted
16 May 2025
Start date
1 Feb 2025
Primary completion date
30 May 2026
Lead sponsor
Tongji Hospital
NCT number
NCT07019246

What you commit to

  • Study type: Interventional
  • Planned participants: 166
  • From 1 Feb 2025 to the primary completion date, 30 May 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Liver surgery, renal surgery, adrenal surgery, day surgery;

Other illness

  • Septic shock and multiple organ failure diagnosed within 14 days;
  • Stroke or transient ischemic attack within 3 months;
  • Patients with unstable angina pectoris or myocardial infarction within 3 months; Arrhythmia requiring treatment was not treated or treatment did not meet expectations;
  • Resting blood pressure ≥180/110 mmHg (2020 ISH hypertension guideline ≥ grade 3 hypertension); Or systolic blood pressure \<90mmHg or mean blood pressure \<65mmHg.
  • Taking corticosteroids or other immunosuppressants for more than 10 days within 6 months or having a history of adrenal cortex suppression or immune system diseases;

Lab values

  • Hyperkalemia (serum potassium \>5.5mmol/L) within 48 hours;
  • Patients with preoperative diagnosed diabetes mellitus and uncontrolled blood glucose; Diabetic complications were diagnosed before surgery, including diabetic ketoacidosis, hyperosmolar coma, diabetes-related infection, diabetic nephropathy, retinopathy, diabetic cardiomyopathy, diabetic neuropathy, diabetic foot, etc.

Other

  • Severe liver and renal dysfunction;

Who the study is looking for

  • ASA Ⅰ\~Ⅲ;
  • BMI was 18-28 kg/m2;
  • For elective abdominal surgery under intravenous general anesthesia;
  • The expected duration of anesthesia was 1 to 4 hours.

Age in the registry: 65 years to 80 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Tongji Hospital
Coordinator of this site? Confirm its status
WuhanChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.